Listing the recipients of funding, as well as characteristics of the successful institution or researcher, from 2013 onward.
Grant outcomes for the 2022 National Health and Medical Research Council (NHMRC) Grant Application Round will be provided incrementally throughout the year. The outcome datasets may include a small number of schemes for which applications closed in the previous year.
To date, the 2022 NHMRC Grant Application Round has resulted in the commitment of more than $900.0 million to fund 725 grants for health and medical research.
Results of NHMRC grant application rounds
Previous application rounds | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020[1] | 2021 |
---|---|---|---|---|---|---|---|---|---|
[1]Commitments in 2020 were lower than expected due to the delay of the Clinical Trials and Cohort Studies Grant round and Synergy Grant rounds impacted by COVID-19. | |||||||||
Total commitments ($ million) | $812.0 | $780.6 | $896.1 | $828.8 | $877.7 | $783.3 | $923.2 | $760.2 | $986.1 |
Total number of new grants | 1,226 | 1,090 | 1,132 | 1,056 | 1,103 | 1,045 | 857 | 740 | 777 |
Information on the Medical Research Future Fund (MRFF) can be found at Department of Health and Aged Care - MRFF.
Investigator Grant Outcome: Factsheets
The Investigator Grants Outcome Factsheets provide a quick reference point to key statistics on the outcomes of the previous Investigator Grant rounds.
- Investigator Grants Outcome Factsheets – see Downloads section (below).
Ideas Grants Outcomes: Factsheets
The Ideas Grants Outcomes Factsheets provide a quick reference point to key statistics on the outcomes of the 2019 to 2022 Ideas Grant rounds.
- Ideas Grants Outcomes Factsheets – see Downloads section (below).
- Summary of Scores for Ideas Grant Applications – see Downloads section (below).
Clinical Trials and Cohort Studies Grants Outcomes: Factsheets
The Clinical Trials and Cohort Studies Grants Outcomes Factsheets provides a quick reference point to key statistics on the outcomes of the 2019 and 2020 Clinical Trials and Cohort Studies Grant rounds.
- Clinical Trials and Cohort Studies Grants Outcomes Factsheets – see Downloads section (below).
Synergy Grants Outcomes: Factsheets
The Synergy Grants Outcomes Factsheets provides a quick reference point to key statistics on the outcomes of the Synergy Grant rounds.
- Synergy Grants Outcomes Factsheets – see Downloads section (below).
Grant outcomes – under embargo
NHMRC routinely releases grant outcomes to applicants and their institutions under embargo.
This means that the information must not be made public until the embargo is lifted.
During the embargo period, applicants must not publicise the information or post comments about the grant outcomes in public domains such as social forums, websites, journals or newspapers.
The embargo applies to all applicants, including those who have been unsuccessful.
Why are grant outcomes released under embargo?
Embargoes ensure the public announcement of outcomes has the greatest possible impact in promoting health and medical research and researchers to the community.
NHMRC releases results under embargo as soon as possible after Ministerial approval so that applicants and institutions can plan accordingly.
What can applicants do during the embargo?
During the embargo period, applicants can share outcomes with the research team and partner organisations (where applicable), but must advise them of the embargo.
Successful applicants can prepare for the research to start on time. This includes seeking necessary approvals (for example, ethics approvals), recruiting staff and making arrangements with partner organisations. Successful applicants can add grants to their CV for review (for example, as part of a new grant application) provided they add the words 'under embargo'.
Research projects can commence if the embargo continues past the commencement date.
Notification that an embargo is lifted
NHMRC will notify Administering Institutions through an RAO Alert when an embargo is lifted. Once this occurs, applicants may share outcomes publicly.